🚧 Under construction — Data may be inaccurate. We are actively adding more companies and metrics.

Regeneron Pharmaceuticals, Inc. vs Bajaj Finance Limited

Market cap comparison over time

Regeneron Pharmaceuticals, Inc.

$80.6B

Rank #200

Bajaj Finance Limited

$81.6B

Rank #197

Market Cap Over Time

Key Moments

  • Bajaj Finance Limited overtook Regeneron Pharmaceuticals, Inc. by 2026

Year-by-Year Comparison

YearRegeneron Pharmaceuticals, Inc.Bajaj Finance LimitedLeader
2026$80.6B$81.6BBajaj Finance Limited
2025$79.3B$73.6BRegeneron Pharmaceuticals, Inc.
2024$72.8B$50.6BRegeneron Pharmaceuticals, Inc.
2023$89.7B$54.1BRegeneron Pharmaceuticals, Inc.
2022$73.7B$48.3BRegeneron Pharmaceuticals, Inc.
2021$64.5B$51.1BRegeneron Pharmaceuticals, Inc.
2020$49.4B$38.7BRegeneron Pharmaceuticals, Inc.
2019$38.4B$30.9BRegeneron Pharmaceuticals, Inc.
2018$38.2B$19.3BRegeneron Pharmaceuticals, Inc.
2017$38.4B$12.8BRegeneron Pharmaceuticals, Inc.
2016$37.5B$6.1BRegeneron Pharmaceuticals, Inc.
2015$55.5B$4.3BRegeneron Pharmaceuticals, Inc.
2014$41.9B$2.5BRegeneron Pharmaceuticals, Inc.
2013$28.1B$1.1BRegeneron Pharmaceuticals, Inc.
2012$17.5B$928.4MRegeneron Pharmaceuticals, Inc.
2011$5.7B$410.7MRegeneron Pharmaceuticals, Inc.
2010$3.4B$468.9MRegeneron Pharmaceuticals, Inc.
2009$2.5B$217.3MRegeneron Pharmaceuticals, Inc.
2008$1.9B$41.6MRegeneron Pharmaceuticals, Inc.
2007$2.5B$283.7MRegeneron Pharmaceuticals, Inc.
2006$2.1B$234.7MRegeneron Pharmaceuticals, Inc.
2005$1.6B$255.5MRegeneron Pharmaceuticals, Inc.
2004$941.1M$72.5MRegeneron Pharmaceuticals, Inc.
2003$1.5B$48.6MRegeneron Pharmaceuticals, Inc.
2002$1.9B$23.1MRegeneron Pharmaceuticals, Inc.